High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination-Reference-Cited by-同舟云学术

High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination

Published:2009-05 Issue:2 Volume:387 Page:414-426
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Davis Katie L.,Gray Elin S.,Moore Penny L.,Decker Julie M.,Salomon Aidy,Montefiori David C.,Graham Barney S.,Keefer Michael C.,Pinter Abraham,Morris Lynn,Hahn Beatrice H.,Shaw George M.

Publisher

Elsevier BV

Subject

Virology

Reference42 articles.

1. Development of the antibody response in acute HIV-1 infection;Aasa-Chapman;Aids,2004

2. Profiling the specificity of neutralizing antibodies in a large panel of HIV-1 plasmas from subtype B and C chronic infections;Binley;J. Virol.,2008

3. Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site;Bottiger;J. Virol.,1990

4. HIV vaccine design and the neutralizing antibody problem;Burton;Nat. Immunol.,2004

5. Structure of an unliganded simian immunodeficiency virus gp120 core;Chen;Nature,2005

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous neutralizing antibody responses after antiretroviral therapy in acute and early HIV-1;Journal of Clinical Investigation;2024-04-23

2. Broadly neutralizing antibody epitopes on HIV-1 particles are exposed after virus interaction with host cells;Journal of Virology;2023-09-28

3. Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques;PLOS Pathogens;2023-07-03

4. Autologous neutralizing antibodies increase with early antiretroviral therapy and shape HIV rebound after treatment interruption;Science Translational Medicine;2023-05-10

5. Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies;Journal of Virology;2023-02-28